原发性高草酸尿症 - Suppr

Suppr

超能文献

Primary Hyperoxaluria.

作者信息

Xie Xiaotong, Zhang Xiaoliang

机构信息

Zhongda Hospital Southeast University, Nanjing, China

出版信息

N Engl J Med. 2022 Mar 10;386(10):976. doi: 10.1056/NEJMicm2113369. Epub 2022 Mar 5.

DOI:10.1056/NEJMicm2113369

PMID:35245013

Abstract

摘要

相似文献

Primary Hyperoxaluria.

N Engl J Med. 2022 Mar 10;386(10):976. doi: 10.1056/NEJMicm2113369. Epub 2022 Mar 5.

Pediatrics: Timely diagnosis of primary hyperoxaluria type 1.

Nat Rev Nephrol. 2009 Dec;5(12):670-1. doi: 10.1038/nrneph.2009.186.

Oxalosis with nephrocalcinosis.

Nephrol Dial Transplant. 2000 Jan;15(1):124-5. doi: 10.1093/ndt/15.1.124.

Atypical features of primary hyperoxaluria in end-stage renal disease.

Am J Nephrol. 1991;11(4):301-4. doi: 10.1159/000168326.

[Delayed diagnosis of primary hyperoxaluria in a young patient with advanced chronic renal failure].

Nefrologia. 2011;31(2):227-9. doi: 10.3265/Nefrologia.pre2010.Nov.10725.

Off-center fold: necrotizing livedo reticularis. Diagnosis: primary hyperoxaluria type I.

Arch Dermatol. 2001 Jul;137(7):957-62.

Comprehensive evaluation of patients with primary hyperoxaluria type 1: A nationwide study.

Nephrology (Carlton). 2024 Apr;29(4):201-213. doi: 10.1111/nep.14273. Epub 2024 Jan 30.

Primary hyperoxaluria type 2.

Eur J Pediatr. 1997 Jul;156(7):509-12. doi: 10.1007/s004310050649.

Primary hyperoxaluria causing ESRD and gangrene of extremities leading to amputation.

Hemodial Int. 2009 Jul;13(3):266-70. doi: 10.1111/j.1542-4758.2009.00350.x. Epub 2009 Jun 22.

Late diagnosis of primary hyperoxaluria after failed kidney transplantation.

Int Urol Nephrol. 2010 Sep;42(3):825-9. doi: 10.1007/s11255-009-9690-2. Epub 2009 Dec 18.

引用本文的文献

The efficacy and safety of RNA interference for the treatment of primary hyperoxaluria: a systematic review and meta-analysis.

Clin Kidney J. 2024 Nov 29;18(4):sfae383. doi: 10.1093/ckj/sfae383. eCollection 2025 Apr.

Rapid Corneal Calcification Following Endothelial Keratoplasty: A Case Report.

Cureus. 2024 May 23;16(5):e60956. doi: 10.7759/cureus.60956. eCollection 2024 May.

Oxalate as a potent promoter of kidney stone formation.

Front Med (Lausanne). 2023 Jun 5;10:1159616. doi: 10.3389/fmed.2023.1159616. eCollection 2023.

Case report: Acute oxalate nephropathy due to traditional medicinal herbs.

Front Med (Lausanne). 2022 Dec 1;9:1063681. doi: 10.3389/fmed.2022.1063681. eCollection 2022.

Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical Studies.

ACS Pharmacol Transl Sci. 2022 Sep 21;5(11):1007-1016. doi: 10.1021/acsptsci.2c00110. eCollection 2022 Nov 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Primary Hyperoxaluria.

N Engl J Med. 2022 Mar 10;386(10):976. doi: 10.1056/NEJMicm2113369. Epub 2022 Mar 5.

Pediatrics: Timely diagnosis of primary hyperoxaluria type 1.

Nat Rev Nephrol. 2009 Dec;5(12):670-1. doi: 10.1038/nrneph.2009.186.

Oxalosis with nephrocalcinosis.

Nephrol Dial Transplant. 2000 Jan;15(1):124-5. doi: 10.1093/ndt/15.1.124.

Atypical features of primary hyperoxaluria in end-stage renal disease.

Am J Nephrol. 1991;11(4):301-4. doi: 10.1159/000168326.

[Delayed diagnosis of primary hyperoxaluria in a young patient with advanced chronic renal failure].

Nefrologia. 2011;31(2):227-9. doi: 10.3265/Nefrologia.pre2010.Nov.10725.

Off-center fold: necrotizing livedo reticularis. Diagnosis: primary hyperoxaluria type I.

Arch Dermatol. 2001 Jul;137(7):957-62.

Comprehensive evaluation of patients with primary hyperoxaluria type 1: A nationwide study.

Nephrology (Carlton). 2024 Apr;29(4):201-213. doi: 10.1111/nep.14273. Epub 2024 Jan 30.

Primary hyperoxaluria type 2.

Eur J Pediatr. 1997 Jul;156(7):509-12. doi: 10.1007/s004310050649.

Primary hyperoxaluria causing ESRD and gangrene of extremities leading to amputation.

Hemodial Int. 2009 Jul;13(3):266-70. doi: 10.1111/j.1542-4758.2009.00350.x. Epub 2009 Jun 22.

Late diagnosis of primary hyperoxaluria after failed kidney transplantation.

Int Urol Nephrol. 2010 Sep;42(3):825-9. doi: 10.1007/s11255-009-9690-2. Epub 2009 Dec 18.

引用本文的文献

The efficacy and safety of RNA interference for the treatment of primary hyperoxaluria: a systematic review and meta-analysis.

Clin Kidney J. 2024 Nov 29;18(4):sfae383. doi: 10.1093/ckj/sfae383. eCollection 2025 Apr.

Rapid Corneal Calcification Following Endothelial Keratoplasty: A Case Report.

Cureus. 2024 May 23;16(5):e60956. doi: 10.7759/cureus.60956. eCollection 2024 May.

Oxalate as a potent promoter of kidney stone formation.

Front Med (Lausanne). 2023 Jun 5;10:1159616. doi: 10.3389/fmed.2023.1159616. eCollection 2023.

Case report: Acute oxalate nephropathy due to traditional medicinal herbs.

Front Med (Lausanne). 2022 Dec 1;9:1063681. doi: 10.3389/fmed.2022.1063681. eCollection 2022.

Nedosiran, a Candidate siRNA Drug for the Treatment of Primary Hyperoxaluria: Design, Development, and Clinical Studies.

ACS Pharmacol Transl Sci. 2022 Sep 21;5(11):1007-1016. doi: 10.1021/acsptsci.2c00110. eCollection 2022 Nov 11.